| Literature DB >> 23841022 |
K Bo Foreman1, Stuart Sondrup, Christopher Dromey, Eon Jarvis, Shawn Nissen, Leland E Dibble.
Abstract
Purpose. Persons with Parkinson disease (PD) demonstrate deficits in motor learning as well as bidirectional interference (the performance of one task concurrently interferes with the performance of another task) during dual-task performance. Few studies have examined the practice dosages necessary for behavioral change in rehabilitation relevant tasks. Therefore, to compare the effects of age and PD on motor learning during dual-task performance, this pilot study examined persons with PD as well as neurologically healthy participants during concurrent performance of postural and speaking tasks. Methods. Seven persons with PD and 7 healthy age-matched and 10 healthy young control subjects were tested in a motion capture facility. Task performances were performed concurrently and recorded during 3 time periods (acquisition (beginning and ending), 48-hour retention, and 1-week retention). Postural control and speech articulatory acoustic variables were measured. Results. Healthy young participants consistently performed better than other groups on all measured postural and speech variables. Healthy young participants showed decreased variability at retention, while persons with PD and healthy age-matched controls were unable to consistently improve their performance as a result of practice. No changes were noted in the speech variables. Conclusion. The lack of consistent changes in motor performance in any of the tasks, except in the healthy young group, suggests a decreased efficiency of motor learning in the age-matched and PD groups and argues for increased practice dosages during balance training.Entities:
Year: 2013 PMID: 23841022 PMCID: PMC3693179 DOI: 10.1155/2013/987621
Source DB: PubMed Journal: Parkinsons Dis ISSN: 2042-0080
Participant demographics.
| Groups | |||
|---|---|---|---|
| Variable | HY group | AM group | PD group |
| n (gender) | 10 (M = 4; F = 6) | 7 (M = 5; F = 2) | 7 (M = 7; F = 0) |
| Age | 25.50 (2.40) | 70.50 (11.90) | 68.70 (9.20) |
| Time since diagnosis | 4.11 (2.31) | ||
| Disease severity* (modified HY) | 2 (1.5–3) | ||
| Taking carbidopa/levodopa | Yes: 6 | ||
| Dysarthria severity (1–10)* | 4.1 (1–7) | ||
| 6-month fall history | >2 falls: 3 | ||
HY group: healthy young adult controls; AM group: healthy age-matched controls; PD group: persons with PD.
*Median (range).
Values (SD) for each postural control measure at acquisition and retention phases for each group.
| Acquisition (baseline) | Acquisition (ending) | Retention 48 hrs | Retention 1 week | |
|---|---|---|---|---|
| Block 1 | Block 7 | Block 1 | Block 1 | |
| mean (SD) | mean (SD) | mean (SD) | mean (SD) | |
| Reaction time (sec) | ||||
| HY group | 0.66 (0.16) | 0.59 (0.14) | 0.61 (0.10) | 0.67 (0.11) |
| AM group | 0.76 (0.21) | 0.74 (0.36) | 0.70 (0.25) | 0.75 (0.29) |
| PD group | 0.79 (0.20) | 0.67 (0.36) | 0.78 (0.22) | 0.73 (0.10) |
| COP Vel (mm/sec) | ||||
| HY group | 381.39 (166.64)∗,# | 473.26 (146.95) | 446.85 (179.12) | 503.16 (217.22) |
| AM group | 263.30 (184.21) | 227.08 (227.76) | 331.05 (301.86) | 238.58 (229.46) |
| PD group | 97.13 (261.83) | 113.45 (235.31) | 108.02 (219.66) | 139.39 (219.58) |
| COP_COM diff (mm) | ||||
| HY group | 52.84 (21.69)* | 62.74 (26.56) | 59.97 (24.40) | 62.65 (22.95) |
| AM group | 41.18 (26.45) | 40.58 (9.75) | 44.88 (19.60) | 43.73 (14.40) |
| PD group | 18.43 (25.80) | 23.40 (23.15) | 27.72 (21.49) | 31.23 (26.52) |
| Heel Height CV (%) | ||||
| HY group | 3.86 (2.50)∗,∗∗ | 2.79 (4.10) | 2.58 (1.70) | 2.07 (3.30) |
| AM group | 2.43 (4.70) | 3.72 (8.80) | 3.01 (22.50) | 2.18 (13.80) |
| PD group | 14.35 (5.08) | 24.74 (43.30) | 13.59 (43.90) | 9.03 (27.50) |
HY group: healthy young adult controls; AM group: healthy age-matched controls; PD group: persons with PD.
All values: median (interquartile range).
*Significant difference between groups.
**Significant difference between acquisition block 1 (baseline) and block 1 at 48 hr retention and block 1 at 1 wk retention.
#Significant difference between acquisition block 1 and 7.
Articulatory acoustic measures for /ɔɪ/ diphthong at acquisition and retention phases for each group.
| Acquisition (Baseline) | Acquisition (Ending) | Retention 48 hrs | Retention 1 week | |
|---|---|---|---|---|
| Block 1 | Block 7 | Block 1 | Block 1 | |
| mean (SD) | mean (SD) | mean (SD) | mean (SD) | |
| / | ||||
| HY group | 0.11 (0.03) | 0.09 (0.04) | 0.10 (0.03) | 0.10 (0.03) |
| AM group | 0.11 (0.05) | 0.11 (0.04) | 0.11 (0.04) | 0.11 (0.04) |
| PD group | 0.12 (0.03) | 0.11 (0.02) | 0.12 (0.02) | 0.12 (0.03) |
| / | ||||
| HY group | 87.17 (60.83) | 66.83 (84.08) | 63.17 (44.42) | 56.83 (77.75) |
| AM group | 108.66 (66.39) | 75.67 (45.25) | 61.67 (77.00) | 59.00 (68.50) |
| PD group | 78.67 (80.83) | 74.16 (48.33) | 44.50 (56.12) | 47.67 (24.67) |
| / | ||||
| HY group | 1066.00 (404.83) | 938.17 (331.63) | 997.33 (332.00) | 915.00 (404.08) |
| AM group | 1062.67 (302.67) | 966.33 (248.08) | 967.33 (273.92) | 914.67 (231.17) |
| PD group | 859.67 (219.00) | 807.67 (290.00) | 864.67 (268.33) | 810.00 (308.17) |
| / | ||||
| HY group | −0.78 (0.46) | −0.80 (1.01) | −0.67 (0.52) | −0.65 (1.12) |
| AM group | −0.89 (1.34) | −0.70 (0.68) | −0.49 (1.20) | −0.76 (1.14) |
| PD group | −0.68 (0.96) | −0.70 (0.47) | −0.30 (0.70) | −0.39 (0.63) |
| / | ||||
| HY group | 9.72 (3.20) | 9.96 (4.22) | 10.77 (4.58) | 9.65 (4.93) |
| AM group | 11.19 (6.16) | 9.64 (4.68) | 10.13 (4.79) | 10.96 (3.76) |
| PD group | 7.11 (2.62)* | 7.41 (2.67) | 6.96 (1.04) | 6.44 (3.46) |
HY group: healthy young adult controls; AM group: healthy age-matched controls; PD group: persons with PD.
All values: median (interquartile range).
*Significant difference between groups.